EUVIMEDOpdag EUVIMED
Crossref

Ascorbic Acid Reprograms Epigenome and Epitranscriptome by Reducing Fe(III) in the Catalytic Cycle of Dioxygenases

Weizhi He, Xiaotong Yin, Chu Xu, Xiangyue Liu, Yue Huang, Caiguang Yang, Yanhui Xu, Lulu Hu iD

ACS Chemical Biology · 2024

DOI: 10.1021/acschembio.3c00567 ↗

At a glance

Journal article in ACS Chemical Biology, 2024. Written by Weizhi He and 7 co-authors. Institution: Cancer Institute, Fudan university Shanghai Cancer Center, Institutes of Biomedical Sciences, Shanghai Key Laboratory of Medical Epigenetics, Interna…. Major MEDLINE topics: Dioxygenases. Cited 9 times so far (Crossref); 44 references. Funded by: Natural Science Foundation of Shanghai Municipality, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Ascorbic acid (ASC) has been reported to stimulate DNA iterative oxidase ten-eleven translocation (TET) enzymes, Jumonji C-domain-containing histone demethylases, and potentially RNA m6A demethylases FTO and ALKBH5 as a cofactor. Although ascorbic acid has been widely investigated in reprogramming DNA and histone methylation status in vitro, in cultured cells and mouse models, its specific role in the catalytic cycle of dioxygenases remains enigmatic. Here, we systematically investigated the stimulation of ASC toward TET2, ALKBH3, histone demethylases, and FTO. We find that ASC reprograms epitranscriptome by erasing the hypermethylated m6A sites in mRNA. Biochemistry and electron spin resonance assays demonstrate that ASC enters the active pocket of dioxygenases and reduces Fe(III), either incorporated upon protein synthesis or generated upon rebounding the hydroxyl radical during oxidation, into Fe(II). Finally, we propose a remedied model for the catalytic cycle of dioxygenases by adding in the essential cofactor, ASC, which refreshes and regenerates inactive dioxygenase through recycling Fe(III) into Fe(II) in a dynamic "hit-and-run" manner.

Subjects

MeSH terms (MEDLINE)

DioxygenasesAnimalsMiceAscorbic AcidFerric CompoundsEpigenomeJumonji Domain-Containing Histone DemethylasesHistone DemethylasesFerrous CompoundsDNADNA Methylation

Substances

DioxygenasesAscorbic AcidFerric CompoundsJumonji Domain-Containing Histone DemethylasesHistone DemethylasesFerrous CompoundsDNA

Authors and institutions

  • Cancer Institute, Fudan university Shanghai Cancer Center, Institutes of Biomedical Sciences, Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism (Ministry o…
  • State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

ORCID profiles: Lulu Hu

Funding

  • Natural Science Foundation of Shanghai Municipality
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Cite

APA

He, W., Yin, X., Xu, C., Liu, X., Huang, Y., Yang, C., Xu, Y., & Hu, L. (2024). Ascorbic Acid Reprograms Epigenome and Epitranscriptome by Reducing Fe(III) in the Catalytic Cycle of Dioxygenases. ACS Chemical Biology. https://doi.org/10.1021/acschembio.3c00567

Vancouver

He W, Yin X, Xu C, Liu X, Huang Y, Yang C, et al. Ascorbic Acid Reprograms Epigenome and Epitranscriptome by Reducing Fe(III) in the Catalytic Cycle of Dioxygenases. ACS Chemical Biology. 2024. doi:10.1021/acschembio.3c00567

BibTeX
@article{He2024,
  author = {He, Weizhi and Yin, Xiaotong and Xu, Chu and Liu, Xiangyue and Huang, Yue and Yang, Caiguang and Xu, Yanhui and Hu, Lulu},
  title = {Ascorbic Acid Reprograms Epigenome and Epitranscriptome by Reducing Fe(III) in the Catalytic Cycle of Dioxygenases},
  journal = {ACS Chemical Biology},
  year = {2024},
  doi = {10.1021/acschembio.3c00567}
}
Start for free →